July 2018
Volume 59, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2018
Combined blockade of VEGFR-3 and Itga-9 promotes lamellar corneal transplant survival
Author Affiliations & Notes
  • Meng Shi
    Vision Science Graduate Program, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, Berkeley, California, United States
  • Ziya Zhang
    Vision Science Graduate Program, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, Berkeley, California, United States
  • Guangyu Li
    Vision Science Graduate Program, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, Berkeley, California, United States
  • Yasuyuki Yokosaki
    Cell-Matrix Frontier Laboratory, Biomedical Research Unit, Hiroshima, Japan
  • David G. Hwang
    Department of Ophthalmology, San Francisco, California, United States
  • Lu Chen
    Vision Science Graduate Program, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Meng Shi, None; Ziya Zhang, None; Guangyu Li, None; Yasuyuki Yokosaki, None; David Hwang, None; Lu Chen, None
  • Footnotes
    Support  This work is supported in part by research grants from NIH and University of California at Berkeley (LC).
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 508. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Meng Shi, Ziya Zhang, Guangyu Li, Yasuyuki Yokosaki, David G. Hwang, Lu Chen; Combined blockade of VEGFR-3 and Itga-9 promotes lamellar corneal transplant survival
      . Invest. Ophthalmol. Vis. Sci. 2018;59(9):508. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Lamellar corneal transplantation is an innovative surgical procedure that replaces partial thickness cornea and has evolved as a new trend to treat corneal stromal disorders. We have recently reported that this procedure induces lymphangiogenesis (LG) and valvulogenesis (VG), which are mediators of transplant rejection. In this study, we investigated the effects of a combined blockade of VEGFR-3 (vascular endothelial growth factor receptor-3) and Itga-9 (integrin alpha9beta1) on the processes of LG and VG and graft survival after lamellar transplantation.

Methods : Lamellar corneal transplantation was performed between fully mismatched BALB/c (donor) and Prox-1-GFP (green fluorescent protein) mice in C57BL/6 background (recipient). The recipient mice were randomized to receive neutralizing antibodies of VEGFR-3 (kindly provided by Eli Lilly and Company) and Itga-9. Processes of corneal LG and VG were assessed in vivo by our advanced live imaging system, and lamellar grafts were evaluated by ophthalmic slit-lamp microscopy as well.

Results : Combined blockade of VEGFR-3 and Itga-9 markedly inhibited both LG and VG after lamellar transplantation. This treatment also promoted graft survival.

Conclusions : This study not only offers new insights into lamellar transplant rejection but also provides a novel strategy to manage it and possibly other lymphatic- and immune-related diseases in the body.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×